BioNTech’s CEO said on Tuesday that while it is currently unclear whether the vaccine can protect against the new U.K. strain, it is “highly likely” the shot can protect against new variants.
BioNTech’s CEO said on Tuesday that while it is currently unclear whether the vaccine can protect against the new U.K. strain, it is “highly likely” the shot can protect against new variants.